Cuídate con Radio 5 Cuídate con Radio 5 – «Salud mental: duelos invisibles» – 15/09/26
El laboratorio de JAL El laboratorio de JAL – La obesidad como enfermedad – 15/09/26
Mayo Clinic Talks 684: An Update on Glaucoma
Host: Darryl S. Chutka, M.D. Guest: Cheryl L. Khanna, M.D. Glaucoma is one of the leading causes of blindness worldwide and is characterized by progressive optic nerve damage often but not always associated with elevated intraocular...
Dermotheque, un podcast de dermatología hecho por dermatólogas 2: 136 – Volvemos a hablar del acné de la mujer adulta
El acné de la mujer adulta no es solo una prolongación del acné adolescente: en él intervienen hormonas, inflamación, microbioma y alteraciones de la barrera cutánea.En este episodio, Sara...
Neurology® Podcast Integrating, Educating, and Implementing Systems of Care Around Brain Health – Part 2
In part two of this two-part series, recorded at this year's AAN Annual Meeting, Dr. Gregg Day talks with Drs. Joel Salinas and Sarah Song about imperfect but practical...
ScienceLink Vacunas y cáncer:cuáles sí, cuáles no y por qué
En este episodio del pódcast “Más allá del cáncer”, se aborda la importancia de las estrategias de vacunación en pacientes con neoplasias sólidas y hematológicas. El Dr. Héctor Raúl...
Cuídate con Radio 5 Cuídate con Radio 5 – Tiroides: la mariposa que mueve tu cuerpo – 14/09/26
Tras la tormenta Tras la tormenta | Gonzalo Rodríguez-Fraile II [4x3b]
Tras la tormenta Tras la tormenta | Comprender para dejar de sufrir: Gonzalo Rodríguez-Fraile [4x3a]
Frankly Speaking About Family Medicine Abdominal Obesity and Menopausal Symptoms: Recognizing the Connection, Personalizing Care – Frankly Speaking Ep 502
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-502 Overview: Abdominal obesity can influence both the severity of menopausal symptoms and treatment decisions. Listen...
MDS Podcast Setting the TEMPO: What have we learned about D1/D5 dopamine stimulation in Parkinson’s disease?
Dr. Divyani Garg speaks with Dr. Hubert H. Fernandez about tavapadon, a once-daily selective dopamine D1/D5 receptor agonist, and what the TEMPO clinical development program tells us about its...